Krystal Biotech, Inc. KRYS Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s net margin?
- Krystal Biotech, Inc. (KRYS) reported net margin of 53.9% in Q1 2026.
- How has Krystal Biotech, Inc.'s net margin changed year-over-year?
- Krystal Biotech, Inc.'s net margin increased by 45.1% year-over-year, from 37.2% to 53.9%.
- What is the long-term trend for Krystal Biotech, Inc.'s net margin?
- Over 2 years (2023 to 2025), Krystal Biotech, Inc.'s net margin has grown at a 56.2% compound annual growth rate (CAGR), from 21.6% to 52.6%.
- What does net margin mean?
- The share of every sales dollar that becomes bottom-line profit.
- How do you interpret net margin?
- Higher is better, but net margin mixes operating performance with financing and tax effects and one-off items — read it alongside operating margin to separate the operating story from the rest.
- How does net margin compare across companies?
- Comparable across peers but sensitive to leverage and tax structure; two operationally identical firms can show different net margins purely from financing.